As depicted in Figure 6B, PAR2 was found to be, on average, significantly (p<0.05) overexpressed in CRC samples with higher development grade, whereas CyclinD1 and miR-34a showed no significant changes (Figure 6B). Here, F2RL1 is linked to colorectal carcinoma.